Impact of fibrinolytics on the outcome of empyema in South African children.

BACKGROUND Childhood pneumonia is common in all countries, and empyema is one of the commonest complications. The role of routine intrapleural fibrinolytics in the management of childhood empyema is not well established in low- and middle-income countries. METHODS We did a prospective observational study of children sequentially hospitalised with empyema between December 2006 and December 2011 in South Africa (SA). Intrapleural tissue plasminogen activator (TPA), administered according to a standard protocol, was introduced in September 2009. Outcomes in children treated with TPA after 2009 were compared with the historical cohort not treated with TPA who met the treatment criteria. RESULTS One hundred and forty-two children with empyema, median age 17 months (interquartile range 8-43), were admitted during the study period. Excluding children who did not have a chest tube inserted and those in whom fibrinolysis was contraindicated, there were 99 patients, 52 of whom received fibrinolytics. Clinical characteristics and empyema aetiology were similar in those who received fibrinolysis and those who did not. Eighteen children (38.3%) not treated with TPA required surgery v. 5 (9.6%) treated with TPA (relative risk 0.25; 95% confidence interval 0.1-0.6). The median duration of hospitalisation was similar in both groups. Complications occurred rarely and with a similar incidence in both groups. In-hospital mortality was low, with two deaths in each group. CONCLUSION Intrapleural TPA resulted in a four-fold reduction in surgery. Fibrinolytics should be used for management of empyema in children in SA.

[1]  Á. Gentile.  [Effects of vaccination on invasive pneumococcal disease in South Africa]. , 2015, Archivos argentinos de pediatria.

[2]  H. Selvadurai,et al.  Intrapleural urokinase versus surgical management of childhood empyema , 2014, Journal of paediatrics and child health.

[3]  H. Schmitt,et al.  Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  S. Madhi,et al.  Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme. , 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  S. Madhi,et al.  Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. , 2013, Vaccine.

[6]  K. O'Brien,et al.  Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries , 2013, Journal of global health.

[7]  E. M. Knott,et al.  Experience with an evidence-based protocol using fibrinolysis as first line treatment for empyema in children. , 2012, Journal of pediatric surgery.

[8]  R. Nir,et al.  Streptokinase fibrinolysis protocol: the advantages of a non-operative treatment for stage II pediatric empyema patients. , 2012, The Israel Medical Association journal : IMAJ.

[9]  R. Holman,et al.  Trends in Hospitalization for Empyema in Alaska Native Children Younger Than 10 Years of Age , 2011, The Pediatric infectious disease journal.

[10]  S. Mahant,et al.  Video-assisted thorascopic surgery vs chest drain with fibrinolytics for the treatment of pleural empyema in children: a systematic review of randomized controlled trials. , 2010, Archives of pediatrics & adolescent medicine.

[11]  Su-Ting T. Li,et al.  Empyema Hospitalizations Increased in US Children Despite Pneumococcal Conjugate Vaccine , 2010, Pediatrics.

[12]  D. Fisman,et al.  Cost-effectiveness of Competing Strategies for the Treatment of Pediatric Empyema , 2008, Pediatrics.

[13]  H. Chuang,et al.  Once‐daily vs. twice‐daily intrapleural urokinase treatment of complicated parapneumonic effusion in paediatric patients: a randomised, prospective study * , 2006, International journal of clinical practice.

[14]  S. Stanojevic,et al.  Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. , 2006, American journal of respiratory and critical care medicine.

[15]  David R Flum,et al.  Primary Operative Versus Nonoperative Therapy for Pediatric Empyema: A Meta-analysis , 2005, Pediatrics.

[16]  Okonkwo Uchenna,et al.  Childhood parapneumonic pleural effusion in Enugu. , 2005, The Nigerian postgraduate medical journal.

[17]  Meenu Singh,et al.  Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children , 2004, Acta paediatrica.

[18]  H. Chuang,et al.  Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. , 2004, Chest.

[19]  J. Hull,et al.  Randomised trial of intrapleural urokinase in the treatment of childhood empyema. , 2002, Thorax.

[20]  M. A. Jackson,et al.  Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. , 2009, Journal of pediatric surgery.